Immediate Impact
52 standout
Citing Papers
Pancreatic cancer
2025 Standout
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Works of Qingqu Guo being referenced
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review
2021
VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Qingqu Guo | 317 | 239 | 85 | 141 | 27 | 585 | |
| Colin Rae | 300 | 194 | 78 | 215 | 25 | 605 | |
| Xinxin Bu | 302 | 222 | 65 | 140 | 19 | 597 | |
| Jing Li | 342 | 187 | 66 | 185 | 41 | 645 | |
| Carlo Ganini | 324 | 158 | 97 | 130 | 29 | 702 | |
| Xianghong Yang | 347 | 286 | 115 | 152 | 36 | 703 | |
| Jiankang Zhu | 383 | 164 | 107 | 239 | 34 | 664 | |
| Chengkun Qin | 327 | 171 | 79 | 237 | 35 | 541 | |
| Seraina Faes | 366 | 151 | 66 | 148 | 22 | 617 | |
| Yanling Chen | 281 | 131 | 78 | 169 | 37 | 562 | |
| Yinghong Zhu | 343 | 126 | 73 | 109 | 33 | 645 |
All Works
Login with ORCID to disown or claim papers
Loading papers...